70 related articles for article (PubMed ID: 24196079)
1. [Third-line therapy in a patient with recurrent colon cancer undergoing hemodialysis].
Matsuda M; Seyama Y; Inada K; Miyata Y; Shida D; Maeshiro T; Miyamoto S; Umekita N
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1397-400. PubMed ID: 24196079
[TBL] [Abstract][Full Text] [Related]
2. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
4. [Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].
Tomita M; Kuboi K; Kameyama N; Mitsuhashi H; Matsumoto N; Hasegawa Y; Sekimoto Y
Gan To Kagaku Ryoho; 2011 Jan; 38(1):121-4. PubMed ID: 21368472
[TBL] [Abstract][Full Text] [Related]
5. [A case of stage IV colon cancer effectively treated with tegafur uracil/calcium folinate in a patient on hemodialysis].
Okamoto K; Kobayashi M; Maeda H; Takeshita A
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1151-3. PubMed ID: 22790059
[TBL] [Abstract][Full Text] [Related]
6. [A case of colon cancer with chronic renal dysfunction responding to effective retreatment with FOLFIRI].
Kitade H; Shimasaki T; Yoshimitsu Y; Okuda M; Hokkoku K; Mori M; Shintaku K; Sakuma H; Ueda H; Nakai M
Gan To Kagaku Ryoho; 2012 Aug; 39(8):1267-70. PubMed ID: 22902456
[TBL] [Abstract][Full Text] [Related]
7. Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness.
Politano S; Overman M; Pathak P; Chadha R; Glover K; Chang DZ; Wolff RA; Hoff PM; Abbruzzese J; Eng C; Kopetz S
Clin Colorectal Cancer; 2008 Jan; 7(1):55-9. PubMed ID: 18279578
[TBL] [Abstract][Full Text] [Related]
8. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent lymph node metastases of advanced colon cancer with penetration of the gastric wall, treated effectively by cetuximab monotherapy as third-line treatment].
Kawakami T; Okuyama Y; Enoki Y; Yoshida N
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1849-51. PubMed ID: 22083195
[TBL] [Abstract][Full Text] [Related]
10. [Bevacizumab therapy for a colorectal cancer patient or hemodialysis with hepatic metastasis].
Sato Y; Doden K; Nishida Y; Shimizu S; Tanaka N; Yagi D; Asaumi Y; Hirano Y; Maeda K; Miyanaga T; Hattori M; Hashizume Y
Gan To Kagaku Ryoho; 2013 May; 40(5):647-50. PubMed ID: 23863592
[TBL] [Abstract][Full Text] [Related]
11. [A case of undifferentiated colon cancer responding to FOLFIRI therapy].
Fujiwara K; Nagayoshi Y; Nakahara C; Yamasaki T; Iwashita T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1525-7. PubMed ID: 21918355
[TBL] [Abstract][Full Text] [Related]
12. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
Uemura N; Yamada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant treatment with cetuximab, 5-Fluorouracil, folinic Acid and oxaliplatin in unresectable retroperitoneal recurrent colon cancer.
Trojan J; Lubomierski N; Lehnert T; Engels K; Zeuzem S; Bechstein WO
Z Gastroenterol; 2008 Aug; 46(8):776-9. PubMed ID: 18759201
[TBL] [Abstract][Full Text] [Related]
14. Metastatic rectal cancer responding to third-line therapy employing bevacizumab after failure of oxaliplatin and irinotecan: case report.
Shitara K; Munakata M; Muto O; Sakata Y
Jpn J Clin Oncol; 2008 Jul; 38(7):493-6. PubMed ID: 18567598
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.
Vincenzi B; Santini D; Russo A; Spoto C; Venditti O; Gasparro S; Rizzo S; Zobel BB; Caricato M; Valeri S; Coppola R; Tonini G
Cancer; 2009 Oct; 115(20):4849-56. PubMed ID: 19626652
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy].
Tanaka K; Hirai K; Ogawa H; Toya H; Totsuka O; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2012 Jun; 39(6):993-5. PubMed ID: 22705700
[TBL] [Abstract][Full Text] [Related]
17. [An elderly colon cancer patient with hepatic, lunge and peritoneal metastases was treated by hepatic arterial infusion and systemic chemotherapy-a case report].
Ando M; Nagahama T; Fukuda A; Ami K; Kurokawa T; Hataji K; Ganno H; Kawasaki N; Arai K; Okada Y; Tei S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2288-90. PubMed ID: 21224550
[TBL] [Abstract][Full Text] [Related]
18. A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: the Pan-European Trial in Adjuvant Colon Cancer 2 study.
Köhne CH; Bedenne L; Carrato A; Bouché O; Popov I; Gaspà L; Valladares M; Rougier P; Gog C; Reichardt P; Wils J; Pignatti F; Biertz F
Eur J Cancer; 2013 May; 49(8):1868-75. PubMed ID: 23571150
[TBL] [Abstract][Full Text] [Related]
19. [A case study of stable disease after hepatic arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable hepatic metastases of colon cancer].
Goi T; Nakazawa T; Koneri K; Murai A; Yamaguchi A
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1393-5. PubMed ID: 24196078
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
